Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Dhg Pharmaceutical Joint-Stock Co?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
89 600
120 500
|
Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Dhg Pharmaceutical Joint-Stock Co hold over its rivals?
What risks and challenges
does Dhg Pharmaceutical Joint-Stock Co face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Dhg Pharmaceutical Joint-Stock Co.
Provide an overview of the primary business activities
of Dhg Pharmaceutical Joint-Stock Co.
What unique competitive advantages
does Dhg Pharmaceutical Joint-Stock Co hold over its rivals?
What risks and challenges
does Dhg Pharmaceutical Joint-Stock Co face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Dhg Pharmaceutical Joint-Stock Co.
Provide P/S
for Dhg Pharmaceutical Joint-Stock Co.
Provide P/E
for Dhg Pharmaceutical Joint-Stock Co.
Provide P/OCF
for Dhg Pharmaceutical Joint-Stock Co.
Provide P/FCFE
for Dhg Pharmaceutical Joint-Stock Co.
Provide P/B
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/S
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/GP
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/EBITDA
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/EBIT
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/OCF
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/FCFF
for Dhg Pharmaceutical Joint-Stock Co.
Provide EV/IC
for Dhg Pharmaceutical Joint-Stock Co.
Show me price targets
for Dhg Pharmaceutical Joint-Stock Co made by professional analysts.
What are the Revenue projections
for Dhg Pharmaceutical Joint-Stock Co?
How accurate were the past Revenue estimates
for Dhg Pharmaceutical Joint-Stock Co?
What are the Net Income projections
for Dhg Pharmaceutical Joint-Stock Co?
How accurate were the past Net Income estimates
for Dhg Pharmaceutical Joint-Stock Co?
What are the EPS projections
for Dhg Pharmaceutical Joint-Stock Co?
How accurate were the past EPS estimates
for Dhg Pharmaceutical Joint-Stock Co?
What are the EBIT projections
for Dhg Pharmaceutical Joint-Stock Co?
How accurate were the past EBIT estimates
for Dhg Pharmaceutical Joint-Stock Co?
Compare the revenue forecasts
for Dhg Pharmaceutical Joint-Stock Co with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Dhg Pharmaceutical Joint-Stock Co and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Dhg Pharmaceutical Joint-Stock Co against its competitors.
Analyze the profit margins
(gross, operating, and net) of Dhg Pharmaceutical Joint-Stock Co compared to its peers.
Compare the P/E ratios
of Dhg Pharmaceutical Joint-Stock Co against its peers.
Discuss the investment returns and shareholder value creation
comparing Dhg Pharmaceutical Joint-Stock Co with its peers.
Analyze the financial leverage
of Dhg Pharmaceutical Joint-Stock Co compared to its main competitors.
Show all profitability ratios
for Dhg Pharmaceutical Joint-Stock Co.
Provide ROE
for Dhg Pharmaceutical Joint-Stock Co.
Provide ROA
for Dhg Pharmaceutical Joint-Stock Co.
Provide ROIC
for Dhg Pharmaceutical Joint-Stock Co.
Provide ROCE
for Dhg Pharmaceutical Joint-Stock Co.
Provide Gross Margin
for Dhg Pharmaceutical Joint-Stock Co.
Provide Operating Margin
for Dhg Pharmaceutical Joint-Stock Co.
Provide Net Margin
for Dhg Pharmaceutical Joint-Stock Co.
Provide FCF Margin
for Dhg Pharmaceutical Joint-Stock Co.
Show all solvency ratios
for Dhg Pharmaceutical Joint-Stock Co.
Provide D/E Ratio
for Dhg Pharmaceutical Joint-Stock Co.
Provide D/A Ratio
for Dhg Pharmaceutical Joint-Stock Co.
Provide Interest Coverage Ratio
for Dhg Pharmaceutical Joint-Stock Co.
Provide Altman Z-Score Ratio
for Dhg Pharmaceutical Joint-Stock Co.
Provide Quick Ratio
for Dhg Pharmaceutical Joint-Stock Co.
Provide Current Ratio
for Dhg Pharmaceutical Joint-Stock Co.
Provide Cash Ratio
for Dhg Pharmaceutical Joint-Stock Co.
What is the historical Revenue growth
over the last 5 years for Dhg Pharmaceutical Joint-Stock Co?
What is the historical Net Income growth
over the last 5 years for Dhg Pharmaceutical Joint-Stock Co?
What is the current Free Cash Flow
of Dhg Pharmaceutical Joint-Stock Co?
Discuss the annual earnings per share (EPS)
trend over the past five years for Dhg Pharmaceutical Joint-Stock Co.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
VN |
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
12.7T VND | 2.6 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
838.8B USD | 18.6 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
375.1B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 6.5 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
213.9B CHF | 3.5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
190.7B CHF | 4.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
164.6B GBP | 4.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
214.1B USD | 3.3 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 70.5 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
134.8B USD | 2.1 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
VN |
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Average P/S:
63.5
2.6
|
5%
|
0.5 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
18.6
|
23%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
4%
|
1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
6.5
|
16%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.5
|
5%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.5
|
3%
|
1.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.1
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.3
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
70.5
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.1
|
-1%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.